A Randomized prospective study comparing efficacy of 0.5% Hyperbaric Levobupivacaine with 0.5% Hyperbaric Bupivacaine for subarachnoid block in Orthopedic lower limb surgeries

Phase 4

Not yet recruiting

• Conditions: Other and unspecified fall on samelevel, (2) ICD-10 Condition: W010||Fall on same level from slipping,tripping and stumbling without subsequent striking against object, (3) ICD-10 Condition: S729||Unspecified fracture of femur,

• Registration Number: CTRI/2023/01/048768
• Lead Sponsor: TATA MAIN HOSPITAL

Brief Summary

Studyto establish onset and duration of sensory block , motorblock andhemodynamic stability after subarachnoidblock in adult patients undergoing Orthopediclower limb surgeries  using 3ml of 0.5% Hyperbaric Levobupivacaine and 3ml 0.5%Hyperbaric Bupivacaine.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-12-20
• Study Start: 2023-01-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Adult (Age ≥ 18.
• 60 Years) undergoing orthopedic lower limb surgeries under Subarachnoid block 2 . ASA grade I and II 3.Anticipated Duration of surgery 120 minutes.

Exclusion Criteria

• Patient refusal to participate in study 2.
• Contraindication to subarachnoid block 3.
• Patients with height < 150 cm or > 180 cm 4.
• Patients with BMI ≥ 30 5.
• Patient with history of allergy to local anaesthetics.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the onset and duration of sensory block with 0.5% Hyperbaric Levobupivacaine and 0.5% Hyperbaric Bupivacaine after subarachnoid block in adult patients undergoing Orthopedic lower limb surgeries .	SEPTEMBER 2022 TO JUNE2024

Secondary Outcome Measures

Name	Time	Method
To determine the following parameters in patients receiving 0.5% Hyperbaric Levobupivacaine and 0.5% Hyperbaric Bupivacaine:	1. Onset and duration of motor block

Trial Locations

Locations (1)

TATA MAIN HOSPITAL; 🇮🇳 Singhbhum, JHARKHAND, India

TATA MAIN HOSPITAL

🇮🇳Singhbhum, JHARKHAND, India

NIHARIKA SINGH

Principal investigator

8218430637

niharikasinghsuman@gmail.com